Jill Wechsler, Pharm Exec’s Washington Correspondent

Jill Wechsler is Pharm Exec's Washington Corespondent


FDA Food Center Reorganization Puts Field Inspections in Limbo

Proposed realignment of the Office of Regulatory Affairs would impact oversight of drugs and medical devices as well.

FDA Resumes In-Person Meetings with Industry…Sort Of

Face-to-face meetings will now include in-person and virtual components.

FDA Seeks to Simplify COVID Vaccination Program

Agency panel backs the use of a common bivalent shot for all patients.

Congressional Probe of Alzheimer’s Drug Hits FDA Interactions with Industry

House report on Aduhelm approval calls for FDA to clarify its role in advising sponsors on drug testing and submissions.

FDA Policy Change Heightens Debate Over Medicated Abortion

Regulation revision now allows pharmacies to dispense mifepristone directly to individuals with a prescription.